This announcement is a separate document:
沃森生物：北京国枫律师事务所关于公司2018年股票期权激励计划之注销股票期权事项的法律意见书
Watson Biotech: Beijing Guofeng Law Firm\'s Legal Opinion on the Cancellation of Stock Options in the Company\'s 2018 Stock Options Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.